2016, Number 4
<< Back Next >>
Acta Med 2016; 14 (4)
Macrolide resistance in Mycoplasma pneumoniae and public health
Rivera A
Language: Spanish
References: 5
Page: 255-257
PDF size: 111.89 Kb.
Text Extraction
No abstract.
REFERENCES
Dreser A, Wirtz J, Corbett KK, Achániz G. Uso de antibióticos en México: revisión de problemas y políticas. Salud Pública Méx. 2008; 50 (Supl. 4): S480-S487.
Ferguson GD, Gadsby NJ, Henderson SS, Hardie A, Kalima P, Morris AC et al. Clinical outcomes and macrolide resistance in Mycoplasma pneumoniae infection in Scotland, UK. J Med Microbiol. 2013; 62 (Pt 12): 1876-1882.
Hong JH, Chun JK, Uh Y, Oh KJ, Kim J, Yoon KJ. Two cases of Mycoplasma pneumoniae pneumonia with A2063G mutation in the 23S rRNA gene in siblings. Ann Lab Med. 2013; 33 (1): 65-68.
Morozumi M, Hasegawa K, Kobayashi R, Inoue N, Iwata S, Kuroki H et al. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation. Antimicrob Agents Chemother. 2005; 49 (6): 2302-2306.
Ye T, Li S, Li Y, Ren T, Liu K. Mycoplasma pneumoniae 23SrRNA gene mutation and mechanisms of macrolide resistance. Lab Med. 2013; 44 (1): 63-68.
Full text